Pantozol /01263202/


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 12.2%
Pain 11.7%
Thrombosis Prophylaxis 10.0%
Chronic Obstructive Pulmonary Disease 7.0%
Nausea 7.0%
Diabetes Mellitus 6.5%
Prophylaxis 4.8%
Depression 4.3%
Pruritus 4.3%
Agitation 3.9%
Constipation 3.9%
Epilepsy 3.5%
Sepsis 3.5%
Sleep Disorder 3.5%
Hyperthyroidism 2.6%
Sedation 2.6%
Cough 2.2%
Hypokalaemia 2.2%
Prophylaxis Against Gastrointestinal Ulcer 2.2%
Restlessness 2.2%
Stevens-johnson Syndrome 32.0%
Toxic Epidermal Necrolysis 32.0%
Hepatic Lesion 8.0%
Swollen Tongue 8.0%
Hepatitis Fulminant 4.0%
Hepatocellular Injury 4.0%
Liver Injury 4.0%
Pruritus 4.0%
Tongue Neoplasm Malignant Stage Unspecified 4.0%
Concomitant
Drug Use For Unknown Indication 30.5%
Hypertension 14.2%
Rheumatoid Arthritis 7.9%
Product Used For Unknown Indication 7.5%
Pain 6.1%
Prophylaxis 5.4%
Multiple Myeloma 3.2%
Paroxysmal Nocturnal Haemoglobinuria 2.9%
Type 2 Diabetes Mellitus 2.9%
Coronary Artery Disease 2.5%
Cardiac Failure 2.4%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Chronic Obstructive Pulmonary Disease 1.8%
Diabetes Mellitus 1.8%
Osteoporosis 1.8%
Thrombosis Prophylaxis 1.7%
Gastritis Prophylaxis 1.4%
Polyneuropathy Alcoholic 1.4%
Renal Transplant 1.4%
Epilepsy 1.3%
Renal Failure Acute 12.5%
Seroma 10.7%
Syncope 7.1%
Liver Injury 6.3%
Tachycardia 6.3%
Vomiting 6.3%
Toxic Epidermal Necrolysis 5.4%
Vesical Fistula 5.4%
Faecaloma 4.5%
Sepsis 4.5%
Cytomegalovirus Infection 3.6%
Gastritis Erosive 3.6%
Prothrombin Time Prolonged 3.6%
Transaminases Increased 3.6%
Weight Decreased 3.6%
Drug Exposure During Pregnancy 2.7%
Gastrointestinal Perforation 2.7%
Necrobiosis Lipoidica Diabeticorum 2.7%
Neutropenia 2.7%
Platelet Count Decreased 2.7%

Drug Data